73,827 XNYS Volume
XNYS 20 Mar, 2025 11:26 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| John Patrick Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 6,032 | 6,032 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 33,086 | 33,086 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 12,407 | 12,407 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.14 per share. | 28 Feb 2025 | 276 | 100,156 (0%) | 0% | 100.1 | 27,639 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.14 per share. | 28 Feb 2025 | 776 | 60,335 (0%) | 0% | 100.1 | 77,709 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.14 per share. | 28 Feb 2025 | 2,187 | 527,070 (0%) | 0% | 100.1 | 219,006 | Encompass Health Common Stock |
| Andrew L. Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.14 per share. | 28 Feb 2025 | 304 | 69,587 (0%) | 0% | 100.1 | 30,443 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.14 per share. | 28 Feb 2025 | 364 | 16,237 (0%) | 0% | 100.1 | 36,451 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.14 per share. | 28 Feb 2025 | 416 | 79,710 (0%) | 0% | 100.1 | 41,658 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.63 per share. | 24 Feb 2025 | 1,079 | 61,111 (0%) | 0% | 100.6 | 108,580 | Encompass Health Common Stock |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.53 per share. | 24 Feb 2025 | 374 | 100,816 (0%) | 0% | 97.5 | 36,476 | Encompass Health Common Stock |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.63 per share. | 24 Feb 2025 | 384 | 100,432 (0%) | 0% | 100.6 | 38,642 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.53 per share. | 24 Feb 2025 | 927 | 62,190 (0%) | 0% | 97.5 | 90,410 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.63 per share. | 24 Feb 2025 | 2,896 | 529,257 (0%) | 0% | 100.6 | 291,424 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.53 per share. | 24 Feb 2025 | 2,488 | 532,153 (0%) | 0% | 97.5 | 242,655 | Encompass Health Common Stock |
| Andrew L. Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.53 per share. | 24 Feb 2025 | 401 | 70,301 (0%) | 0% | 97.5 | 39,110 | Encompass Health Common Stock |
| Andrew L. Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.63 per share. | 24 Feb 2025 | 410 | 69,891 (0%) | 0% | 100.6 | 41,258 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.63 per share. | 24 Feb 2025 | 506 | 16,601 (0%) | 0% | 100.6 | 50,919 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.53 per share. | 24 Feb 2025 | 435 | 17,107 (0%) | 0% | 97.5 | 42,426 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.53 per share. | 24 Feb 2025 | 437 | 80,635 (0%) | 0% | 97.5 | 42,621 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.63 per share. | 24 Feb 2025 | 509 | 80,126 (0%) | 0% | 100.6 | 51,221 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 4,557 | 63,117 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 2,216 | 81,072 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Elissa Joy Charbonneau | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,939 | 17,542 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Andrew L. Price | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,538 | 70,702 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 12,152 | 534,641 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,404 | 101,190 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Andrew L. Price | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 98.29 per share. | 13 Feb 2025 | 5,042 | 69,164 (0%) | 0% | 98.3 | 495,578 | Encompass Health Common Stock |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 83 | 46,105 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 94.38 per share. | 15 Jan 2025 | 375 | 12,632 (0%) | 0% | 94.4 | 35,393 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 16 | 12,257 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edward M. Christie | Director | Grant, award, or other acquisition of securities at price $ 94.40 per share. | 15 Jan 2025 | 292 | 4,709 (0%) | 0% | 94.4 | 27,565 | Encompass Health Common Stock |
| Edward M. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 6 | 4,417 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 25 | 17,137 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 83 | 46,105 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 36 | 19,695 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia A. Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 25 | 13,293 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 25 | 13,647 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.35 per share. | 01 Jan 2025 | 2,291 | 99,786 (0%) | 0% | 92.4 | 211,574 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.35 per share. | 01 Jan 2025 | 12,438 | 58,560 (0%) | 0% | 92.3 | 1,148,649 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.35 per share. | 01 Jan 2025 | 31,609 | 522,489 (0%) | 0% | 92.3 | 2,919,091 | Encompass Health Common Stock |
| Andrew L. Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.35 per share. | 01 Jan 2025 | 2,446 | 74,206 (0%) | 0% | 92.3 | 225,888 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.35 per share. | 01 Jan 2025 | 2,991 | 15,603 (0%) | 0% | 92.4 | 276,219 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.35 per share. | 01 Jan 2025 | 5,917 | 78,856 (0%) | 0% | 92.4 | 546,435 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Nov 2024 | 65,229 | 65,229 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Nov 2024 | 65,229 | 70,998 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 16 | 11,879 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 97.53 per share. | 15 Oct 2024 | 362 | 12,241 (0%) | 0% | 97.5 | 35,306 | Encompass Health Common Stock |
| Edward M. Christie | Director | Grant, award, or other acquisition of securities at price $ 97.63 per share. | 15 Oct 2024 | 283 | 4,411 (0%) | 0% | 97.6 | 27,629 | Encompass Health Common Stock |
| Edward M. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 6 | 4,128 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 81 | 46,022 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 81 | 46,022 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 35 | 19,659 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 24 | 13,622 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia A. Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 24 | 13,268 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.03 per share. | 13 Aug 2024 | 98 | 136,227 (0%) | 0% | 87.0 | 8,529 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 12,260 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 86.33 per share. | 13 Aug 2024 | 12,162 | 136,325 (0%) | 0% | 86.3 | 1,049,945 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.83 per share. | 13 Aug 2024 | 12,260 | 148,487 (0%) | 0% | 35.8 | 439,276 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 16 | 11,437 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 86.63 per share. | 15 Jul 2024 | 426 | 11,863 (0%) | 0% | 86.6 | 36,904 | Encompass Health Common Stock |
| Edward M. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 6 | 3,788 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edward M. Christie | Director | Grant, award, or other acquisition of securities at price $ 86.80 per share. | 15 Jul 2024 | 334 | 4,122 (0%) | 0% | 86.8 | 28,991 | Encompass Health Common Stock |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 24 | 17,074 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 80 | 45,941 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 80 | 45,941 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 35 | 19,624 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia A. Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 24 | 13,244 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 24 | 13,598 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Elissa Joy Charbonneau | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 85.02 per share. | 24 May 2024 | 10,000 | 18,594 (0%) | 0% | 85.0 | 850,200 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 14,543 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 83.94 per share. | 06 May 2024 | 14,543 | 84,773 (0%) | 0% | 83.9 | 1,220,739 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.06 per share. | 06 May 2024 | 14,543 | 99,316 (0%) | 0% | 29.1 | 422,620 | Encompass Health Common Stock |
| Greg D. Carmichael | Director | Purchase of securities on an exchange or from another person at price $ 83.73 per share. | 03 May 2024 | 2,000 | 17,050 (0%) | 0% | 83.7 | 167,460 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 1,978 | 11,421 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edward M. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 1,978 | 3,782 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 1,978 | 15,050 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 1,978 | 45,861 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 1,978 | 45,861 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 1,978 | 19,589 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia A. Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 1,978 | 13,220 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 1,978 | 13,574 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.83 per share. | 30 Apr 2024 | 19,460 | 573,558 (0%) | 0% | 35.8 | 697,252 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 25,516 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 19,460 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Mark J. Tarr | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 83.27 per share. | 30 Apr 2024 | 44,976 | 554,098 (0%) | 0% | 83.3 | 3,745,152 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.06 per share. | 30 Apr 2024 | 25,516 | 599,074 (0%) | 0% | 29.1 | 741,495 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 79.56 per share. | 15 Apr 2024 | 411 | 9,443 (0%) | 0% | 79.6 | 32,699 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 13 | 9,032 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edward M. Christie | Director | Grant, award, or other acquisition of securities at price $ 79.65 per share. | 15 Apr 2024 | 314 | 1,804 (0%) | 0% | 79.6 | 25,010 | Encompass Health Common Stock |
| Edward M. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 2 | 1,490 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 21 | 13,072 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 176 | 162,592 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 79.52 per share. | 15 Apr 2024 | 234 | 162,826 (0%) | 0% | 79.5 | 18,608 | Encompass Health Common Stock |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 184 | 99,938 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 80 | 43,883 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 80 | 43,883 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 33 | 17,611 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia A. Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 21 | 11,242 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 21 | 11,596 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Fay M. Edmund | Sr. Vice Pres. and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 1,890 | 102,077 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John Darby Patrick | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 2,812 | 84,773 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Elissa Joy Charbonneau | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 6,601 | 26,105 (0%) | 0% | 0 | Encompass Health Common Stock | |
| J. Tarr Mark | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 74,711 | 539,309 (0%) | 0% | 0 | Encompass Health Common Stock | |
| E. Douglas Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 27,820 | 130,979 (0%) | 0% | 0 | Encompass Health Common Stock | |
| M. Fay Edmund | Sr. Vice Pres. and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 5,010 | 100,187 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 5,248 | 136,227 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patrick John Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 13,116 | 81,961 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Andrew Price L. | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 5,329 | 74,583 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Charbonneau Joy Elissa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 2,489 | 28,594 (0%) | 0% | 0 | Encompass Health Common Stock | |
| J. Mark Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 14,789 | 554,098 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Price L. Andrew | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 2,069 | 76,652 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joy Charbonneau Elissa | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 434 | 20,366 (0%) | 0% | 75.3 | 32,659 | Encompass Health Common Stock |
| Patrick John Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 397 | 69,354 (0%) | 0% | 75.2 | 29,874 | Encompass Health Common Stock |
| Patrick John Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 509 | 68,845 (0%) | 0% | 75.2 | 38,302 | Encompass Health Common Stock |
| M. Fay Edmund | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 299 | 95,561 (0%) | 0% | 75.3 | 22,500 | Encompass Health Common Stock |
| Tarr Mark J. | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 2,487 | 469,749 (0%) | 0% | 75.3 | 187,147 | Encompass Health Common Stock |
| Joy Elissa Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 356 | 20,010 (0%) | 0% | 75.3 | 26,789 | Encompass Health Common Stock |
| J. Tarr Mark | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 2,256 | 467,493 (0%) | 0% | 75.3 | 169,764 | Encompass Health Common Stock |
| Patrick Darby John | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 437 | 69,751 (0%) | 0% | 75.2 | 32,884 | Encompass Health Common Stock |
| Douglas Coltharp E. | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 927 | 105,078 (0%) | 0% | 75.3 | 69,757 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 1,079 | 103,159 (0%) | 0% | 75.3 | 81,195 | Encompass Health Common Stock |
| Mark Tarr J. | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 2,895 | 464,598 (0%) | 0% | 75.3 | 217,849 | Encompass Health Common Stock |
| E. Douglas Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 840 | 104,238 (0%) | 0% | 75.3 | 63,210 | Encompass Health Common Stock |
| Edmund Fay M. | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 374 | 95,860 (0%) | 0% | 75.3 | 28,144 | Encompass Health Common Stock |
| L. Andrew Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 410 | 69,254 (0%) | 0% | 75.3 | 30,853 | Encompass Health Common Stock |
| Andrew Price L. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 320 | 69,664 (0%) | 0% | 75.3 | 24,080 | Encompass Health Common Stock |
| Fay M. Edmund | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 384 | 95,177 (0%) | 0% | 75.3 | 28,896 | Encompass Health Common Stock |
| Price L. Andrew | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 400 | 69,984 (0%) | 0% | 75.3 | 30,100 | Encompass Health Common Stock |
| Charbonneau Elissa Joy | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 506 | 19,504 (0%) | 0% | 75.3 | 38,077 | Encompass Health Common Stock |
| R. Reidy Christopher | Director | Grant, award, or other acquisition of securities at price $ 70.48 per share. | 16 Jan 2024 | 465 | 9,019 (0%) | 0% | 70.5 | 32,773 | Encompass Health Common Stock |
| Patricia A. Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 24 | 11,221 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Reidy R. Christopher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 14 | 8,554 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Williams Terrance | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 24 | 11,575 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Correll Donald L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 208 | 99,754 (0%) | 0% | 0 | Encompass Health Common Stock | |
| G. Leslye Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 91 | 43,803 (0%) | 0% | 0 | Encompass Health Common Stock | |
| M. Christie Edward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 3 | 1,000 (0%) | 0% | 0 | Encompass Health Common Stock | |
| D. Greg Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 24 | 13,051 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John Chidsey W. | Director | Grant, award, or other acquisition of securities at price $ 70.48 per share. | 16 Jan 2024 | 495 | 162,416 (0%) | 0% | 70.5 | 34,888 | Encompass Health Common Stock |
| Chidsey John W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 199 | 161,921 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edward Christie M. | Director | Grant, award, or other acquisition of securities at price $ 70.51 per share. | 16 Jan 2024 | 488 | 1,488 (0%) | 0% | 70.5 | 34,409 | Encompass Health Common Stock |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 91 | 43,803 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Schlichting M. Nancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 37 | 17,578 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | 16 Jan 2024 | 4 | 13,055 (0%) | 0% | 68.8 | 275 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 24 | 17,112 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | 16 Jan 2024 | 3 | 13,079 (0%) | 0% | 81.3 | 244 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | 16 Jan 2024 | 7 | 17,088 (0%) | 0% | 86.9 | 608 | Encompass Health Common Stock | |
| E. Coltharp Douglas | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.72 per share. | 02 Jan 2024 | 10,288 | 106,005 (0%) | 0% | 66.7 | 686,415 | Encompass Health Common Stock |
| J. Mark Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.72 per share. | 02 Jan 2024 | 25,159 | 472,236 (0%) | 0% | 66.7 | 1,678,608 | Encompass Health Common Stock |
| Price Andrew | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.72 per share. | 02 Jan 2024 | 2,062 | 70,384 (0%) | 0% | 66.7 | 137,577 | Encompass Health Common Stock |
| Darby Patrick John | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.72 per share. | 02 Jan 2024 | 4,920 | 70,188 (0%) | 0% | 66.7 | 328,262 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.72 per share. | 02 Jan 2024 | 2,281 | 20,800 (0%) | 0% | 66.7 | 152,188 | Encompass Health Common Stock |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.72 per share. | 02 Jan 2024 | 1,935 | 96,234 (0%) | 0% | 66.7 | 129,103 | Encompass Health Common Stock |
| Edward M. Christie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2023 | 997 | 997 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2023 | 16,623 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 63.39 per share. | 13 Nov 2023 | 11,215 | 116,293 (0%) | 0% | 63.4 | 710,919 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.55 per share. | 13 Nov 2023 | 16,623 | 127,508 (0%) | 0% | 26.6 | 441,341 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2023 | 16 | 8,536 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 64.50 per share. | 16 Oct 2023 | 4 | 8,540 (0%) | 0% | 64.5 | 258 | Encompass Health Common Stock |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2023 | 27 | 13,027 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 64.58 per share. | 16 Oct 2023 | 541 | 161,722 (0%) | 0% | 64.6 | 34,938 | Encompass Health Common Stock |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2023 | 222 | 161,181 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2023 | 231 | 99,546 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2023 | 101 | 43,712 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2023 | 101 | 43,712 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2023 | 42 | 17,541 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia A. Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2023 | 27 | 11,197 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2023 | 27 | 11,551 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Elissa Joy Charbonneau | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 69.58 per share. | 17 Aug 2023 | 8,294 | 23,081 (0%) | 0% | 69.6 | 577,097 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2023 | 25,330 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Mark J. Tarr | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 71.06 per share. | 16 Aug 2023 | 25,330 | 497,405 (0%) | 0% | 71.1 | 1,799,950 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.55 per share. | 16 Aug 2023 | 25,330 | 522,735 (0%) | 0% | 26.6 | 672,512 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 67.75 per share. | 17 Jul 2023 | 4 | 8,520 (0%) | 0% | 67.8 | 271 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 15 | 8,516 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 25 | 13,000 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 209 | 160,511 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 67.73 per share. | 17 Jul 2023 | 448 | 160,959 (0%) | 0% | 67.7 | 30,343 | Encompass Health Common Stock |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 218 | 99,315 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 95 | 43,611 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 95 | 43,611 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 39 | 17,499 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia A. Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 25 | 11,170 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 25 | 11,524 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 2,385 | 8,501 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 2,385 | 12,975 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 2,385 | 160,302 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 2,385 | 99,097 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 2,385 | 43,516 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 2,385 | 43,516 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 2,385 | 17,460 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia A. Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 2,385 | 11,145 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 2,385 | 11,499 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 11 | 6,112 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 61.50 per share. | 17 Apr 2023 | 4 | 6,116 (0%) | 0% | 61.5 | 246 | Encompass Health Common Stock |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 22 | 10,590 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 223 | 157,230 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 61.51 per share. | 17 Apr 2023 | 687 | 157,917 (0%) | 0% | 61.5 | 42,257 | Encompass Health Common Stock |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 233 | 96,712 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 99 | 41,131 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 99 | 41,131 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 37 | 15,075 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia A. Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 22 | 8,760 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 22 | 9,114 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 18,430 | 18,430 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 49,498 | 49,498 | - | - | Non-qualified Stock Option (Right to Buy) | |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 8,689 | 8,689 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 383 | 98,169 (0%) | 0% | 60.2 | 23,064 | Encompass Health Common Stock |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 299 | 98,552 (0%) | 0% | 60.2 | 18,006 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 840 | 111,963 (0%) | 0% | 60.2 | 50,585 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 1,078 | 110,885 (0%) | 0% | 60.2 | 64,917 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 2,256 | 500,290 (0%) | 0% | 60.2 | 135,856 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 2,895 | 497,395 (0%) | 0% | 60.2 | 174,337 | Encompass Health Common Stock |
| Andrew Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 410 | 72,446 (0%) | 0% | 60.2 | 24,690 | Encompass Health Common Stock |
| Andrew Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 320 | 72,856 (0%) | 0% | 60.2 | 19,270 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 356 | 31,881 (0%) | 0% | 60.2 | 21,438 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 506 | 31,375 (0%) | 0% | 60.2 | 30,471 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 397 | 75,617 (0%) | 0% | 60.2 | 23,907 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 509 | 75,108 (0%) | 0% | 60.2 | 30,652 | Encompass Health Common Stock |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,563 | 98,851 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 4,125 | 96,288 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 37,586 | 112,803 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 22,902 | 75,217 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 61,503 | 485,722 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 16,824 | 502,546 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Andrew Price | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,726 | 73,176 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Andrew Price | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 4,388 | 70,450 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Elissa Joy Charbonneau | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 4,909 | 29,265 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Elissa Joy Charbonneau | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,972 | 32,237 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 17,728 | 76,014 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 10,799 | 58,286 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.86 per share. | 21 Feb 2023 | 278 | 92,163 (0%) | 0% | 62.9 | 17,475 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.86 per share. | 21 Feb 2023 | 782 | 52,315 (0%) | 0% | 62.9 | 49,157 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.86 per share. | 21 Feb 2023 | 2,100 | 424,219 (0%) | 0% | 62.9 | 132,006 | Encompass Health Common Stock |
| Andrew Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.86 per share. | 21 Feb 2023 | 298 | 66,062 (0%) | 0% | 62.9 | 18,732 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.86 per share. | 21 Feb 2023 | 332 | 24,356 (0%) | 0% | 62.9 | 20,870 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.86 per share. | 21 Feb 2023 | 369 | 47,487 (0%) | 0% | 62.9 | 23,195 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.78 per share. | 10 Feb 2023 | 17,895 | 53,097 (0%) | 0% | 60.8 | 1,087,658 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 17,895 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.07 per share. | 10 Feb 2023 | 17,895 | 70,992 (0%) | 0% | 20.1 | 359,153 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 11 | 6,096 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 61.60 per share. | 17 Jan 2023 | 5 | 6,101 (0%) | 0% | 61.6 | 308 | Encompass Health Common Stock |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 22 | 10,568 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 61.65 per share. | 17 Jan 2023 | 682 | 157,007 (0%) | 0% | 61.6 | 42,045 | Encompass Health Common Stock |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 224 | 156,325 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 233 | 96,479 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 99 | 41,032 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 99 | 41,032 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 37 | 15,038 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia A. Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 22 | 8,738 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 22 | 9,092 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.81 per share. | 03 Jan 2023 | 1,259 | 92,441 (0%) | 0% | 59.8 | 75,301 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.81 per share. | 03 Jan 2023 | 6,449 | 53,097 (0%) | 0% | 59.8 | 385,715 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.81 per share. | 03 Jan 2023 | 14,576 | 426,319 (0%) | 0% | 59.8 | 871,791 | Encompass Health Common Stock |
| Andrew Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.81 per share. | 03 Jan 2023 | 1,344 | 66,360 (0%) | 0% | 59.8 | 80,385 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.81 per share. | 03 Jan 2023 | 1,477 | 24,688 (0%) | 0% | 59.8 | 88,339 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.81 per share. | 03 Jan 2023 | 3,113 | 47,856 (0%) | 0% | 59.8 | 186,189 | Encompass Health Common Stock |
| Barbara Jacobsmeyer | President & CEO, HHH | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 2,200 | 57,339 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Purchase of securities on an exchange or from another person at price $ 54.67 per share. | 31 Oct 2022 | 1,830 | 10,546 (0%) | 0% | 54.7 | 100,046 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 49.70 per share. | 17 Oct 2022 | 507 | 6,085 (0%) | 0% | 49.7 | 25,198 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 13 | 5,578 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 27 | 8,716 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 279 | 155,253 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 49.73 per share. | 17 Oct 2022 | 848 | 156,101 (0%) | 0% | 49.7 | 42,171 | Encompass Health Common Stock |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 292 | 96,246 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 123 | 40,933 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 123 | 40,933 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 46 | 15,001 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 27 | 8,716 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 27 | 9,070 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Mark J. Tarr | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 53.25 per share. | 17 Aug 2022 | 20,449 | 440,895 (0%) | 0% | 53.2 | 1,088,909 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2022 | 20,449 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.07 per share. | 17 Aug 2022 | 20,449 | 461,344 (0%) | 0% | 20.1 | 410,411 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 24 | 4,213 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 514 | 127,934 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,226 | 4,189 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,226 | 7,173 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,226 | 127,420 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,226 | 79,447 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,226 | 33,867 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,226 | 33,867 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,226 | 12,347 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,226 | 7,173 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 2,226 | 7,527 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 298 | 82,981 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 72.31 per share. | 18 Apr 2022 | 346 | 1,963 (0%) | 0% | 72.3 | 25,019 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 5 | 1,617 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 20 | 4,947 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 72.33 per share. | 18 Apr 2022 | 633 | 125,194 (0%) | 0% | 72.3 | 45,785 | Encompass Health Common Stock |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 285 | 124,561 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 298 | 81,254 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 72.25 per share. | 18 Apr 2022 | 8 | 81,262 (0%) | 0% | 72.3 | 578 | Encompass Health Common Stock |
| Leo I. Higdon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 298 | 5,104 (0%) | 0% | 0 | Encompass Health Common Stock | |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 72.28 per share. | 18 Apr 2022 | 60 | 99,385 (0%) | 0% | 72.3 | 4,337 | Encompass Health Common Stock |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 298 | 99,325 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 298 | 77,221 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 121 | 31,641 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 121 | 31,641 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Yvonne M. Curl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 298 | 78,458 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 40 | 10,121 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 20 | 4,947 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 20 | 5,301 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 22,728 | 22,728 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 61,039 | 61,039 | - | - | Non-qualified Stock Option (Right to Buy) | |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 10,715 | 10,715 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Barbara Jacobsmeyer | President & CEO, HHH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 22,137 | 22,137 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,180 | 90,348 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.52 per share. | 24 Feb 2022 | 247 | 88,168 (0%) | 0% | 65.5 | 16,183 | Encompass Health Common Stock |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,129 | 92,477 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 11,816 | 54,948 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.52 per share. | 24 Feb 2022 | 698 | 37,078 (0%) | 0% | 65.5 | 45,733 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 6,054 | 43,132 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 31,730 | 428,557 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.52 per share. | 24 Feb 2022 | 1,873 | 380,569 (0%) | 0% | 65.5 | 122,719 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 16,258 | 396,827 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Andrew Price | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,318 | 64,139 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Andrew Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.52 per share. | 24 Feb 2022 | 265 | 61,821 (0%) | 0% | 65.5 | 17,363 | Encompass Health Common Stock |
| Andrew Price | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,264 | 66,403 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.52 per share. | 24 Feb 2022 | 296 | 19,247 (0%) | 0% | 65.5 | 19,394 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,534 | 24,653 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Elissa Joy Charbonneau | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,872 | 22,119 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 5,572 | 48,800 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.52 per share. | 24 Feb 2022 | 330 | 40,374 (0%) | 0% | 65.5 | 21,622 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,854 | 43,228 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Barbara Jacobsmeyer | President & CEO, HHH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 9,875 | 59,539 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Barbara Jacobsmeyer | President & CEO, HHH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 5,897 | 49,664 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Barbara Jacobsmeyer | President & CEO, HHH | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.52 per share. | 24 Feb 2022 | 584 | 43,767 (0%) | 0% | 65.5 | 38,264 | Encompass Health Common Stock |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.91 per share. | 22 Feb 2022 | 507 | 88,415 (0%) | 0% | 65.9 | 33,416 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.91 per share. | 22 Feb 2022 | 1,270 | 37,776 (0%) | 0% | 65.9 | 83,706 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.91 per share. | 22 Feb 2022 | 3,782 | 382,442 (0%) | 0% | 65.9 | 249,272 | Encompass Health Common Stock |
| Andrew Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.91 per share. | 22 Feb 2022 | 525 | 62,086 (0%) | 0% | 65.9 | 34,603 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.91 per share. | 22 Feb 2022 | 604 | 19,543 (0%) | 0% | 65.9 | 39,810 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.91 per share. | 22 Feb 2022 | 673 | 40,704 (0%) | 0% | 65.9 | 44,357 | Encompass Health Common Stock |
| Barbara Jacobsmeyer | President & CEO, HHH | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.91 per share. | 22 Feb 2022 | 1,048 | 44,351 (0%) | 0% | 65.9 | 69,074 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.02 per share. | 08 Feb 2022 | 26,132 | 55,555 (0%) | 0% | 21.0 | 549,295 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 26,132 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.15 per share. | 08 Feb 2022 | 16,509 | 39,046 (0%) | 0% | 62.1 | 1,026,034 | Encompass Health Common Stock |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 62.51 per share. | 21 Jan 2022 | 399 | 1,612 (0%) | 0% | 62.5 | 24,941 | Encompass Health Common Stock |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 62.59 per share. | 20 Jan 2022 | 498 | 124,276 (0%) | 0% | 62.6 | 31,170 | Encompass Health Common Stock |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 343 | 82,683 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 6 | 1,213 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 23 | 4,927 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 328 | 123,547 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 61.21 per share. | 18 Jan 2022 | 231 | 123,778 (0%) | 0% | 61.2 | 14,140 | Encompass Health Common Stock |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 343 | 80,949 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 61.29 per share. | 18 Jan 2022 | 7 | 80,956 (0%) | 0% | 61.3 | 429 | Encompass Health Common Stock |
| Leo I. Higdon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 343 | 4,806 (0%) | 0% | 0 | Encompass Health Common Stock | |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 343 | 98,960 (0%) | 0% | 0 | Encompass Health Common Stock | |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 61.16 per share. | 18 Jan 2022 | 67 | 99,027 (0%) | 0% | 61.2 | 4,098 | Encompass Health Common Stock |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 343 | 76,923 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 139 | 31,520 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 139 | 31,520 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Yvonne M. Curl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 343 | 78,160 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 46 | 10,081 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 23 | 4,927 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 23 | 5,281 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.26 per share. | 03 Jan 2022 | 1,025 | 88,922 (0%) | 0% | 65.3 | 66,892 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.26 per share. | 03 Jan 2022 | 4,226 | 29,423 (0%) | 0% | 65.3 | 275,789 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.26 per share. | 03 Jan 2022 | 11,327 | 386,224 (0%) | 0% | 65.3 | 739,200 | Encompass Health Common Stock |
| Andrew Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.26 per share. | 03 Jan 2022 | 1,031 | 62,611 (0%) | 0% | 65.3 | 67,283 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.26 per share. | 03 Jan 2022 | 1,206 | 20,147 (0%) | 0% | 65.3 | 78,704 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.26 per share. | 03 Jan 2022 | 2,537 | 41,377 (0%) | 0% | 65.3 | 165,565 | Encompass Health Common Stock |
| Barbara Jacobsmeyer | President & CEO, HHH | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.26 per share. | 03 Jan 2022 | 3,455 | 45,399 (0%) | 0% | 65.3 | 225,473 | Encompass Health Common Stock |
| Leo I. Higdon | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Dec 2021 | 75,287 | 75,287 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leo I. Higdon | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Dec 2021 | 75,287 | 4,463 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Purchase of securities on an exchange or from another person at price $ 56.61 per share. | 02 Dec 2021 | 354 | 5,258 (0%) | 0% | 56.6 | 20,040 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Nov 2021 | 44,600 | 33,649 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Nov 2021 | 44,600 | 125,631 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 311 | 82,340 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 5 | 1,207 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 21 | 4,904 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 298 | 123,005 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 66.46 per share. | 15 Oct 2021 | 214 | 123,219 (0%) | 0% | 66.5 | 14,222 | Encompass Health Common Stock |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 66.44 per share. | 15 Oct 2021 | 9 | 80,606 (0%) | 0% | 66.4 | 598 | Encompass Health Common Stock |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 311 | 80,597 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leo I. Higdon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 311 | 79,750 (0%) | 0% | 0 | Encompass Health Common Stock | |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 66.48 per share. | 15 Oct 2021 | 65 | 98,617 (0%) | 0% | 66.5 | 4,321 | Encompass Health Common Stock |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 311 | 98,552 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 311 | 76,580 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 126 | 31,381 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 126 | 31,381 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Yvonne M. Curl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 311 | 77,817 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 42 | 10,035 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 21 | 4,904 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 21 | 4,904 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Christopher R. Reidy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 1,202 | 1,202 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 263 | 82,029 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 18 | 4,883 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 251 | 122,529 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 80.01 per share. | 15 Jul 2021 | 178 | 122,707 (0%) | 0% | 80.0 | 14,242 | Encompass Health Common Stock |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 80.14 per share. | 15 Jul 2021 | 7 | 80,286 (0%) | 0% | 80.1 | 561 | Encompass Health Common Stock |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 263 | 80,279 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leo I. Higdon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 263 | 79,439 (0%) | 0% | 0 | Encompass Health Common Stock | |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 80.04 per share. | 15 Jul 2021 | 53 | 98,241 (0%) | 0% | 80.0 | 4,242 | Encompass Health Common Stock |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 263 | 98,188 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 263 | 76,269 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 106 | 31,255 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 106 | 31,255 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Yvonne M. Curl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 263 | 77,506 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 35 | 9,993 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 18 | 4,883 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 18 | 4,883 (0%) | 0% | 0 | Encompass Health Common Stock | |
| April Kaye Bullock Anthony | CEO & President, Home Health | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jun 2021 | 19,205 | 175,269 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 81,766 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 4,865 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 122,278 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 80,016 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leo I. Higdon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 79,176 (0%) | 0% | 0 | Encompass Health Common Stock | |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 97,925 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 76,006 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 31,149 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 31,149 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Yvonne M. Curl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 77,243 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 9,958 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 4,865 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 1,757 | 4,865 (0%) | 0% | 0 | Encompass Health Common Stock | |
| April Kaye Bullock Anthony | CEO & President, Home Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.68 per share. | 05 May 2021 | 3,533 | 194,239 (0%) | 0% | 84.7 | 299,174 | Encompass Health Common Stock |
| April Kaye Bullock Anthony | CEO & President, Home Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 3,240 | 6,478 | - | - | Non-qualified Stock Option (Right to Buy) | |
| April Kaye Bullock Anthony | CEO & President, Home Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 4,343 | 2,172 | - | - | Non-qualified Stock Option (Right to Buy) | |
| April Kaye Bullock Anthony | CEO & President, Home Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.68 per share. | 05 May 2021 | 3,005 | 194,474 (0%) | 0% | 84.7 | 254,463 | Encompass Health Common Stock |
| April Kaye Bullock Anthony | CEO & President, Home Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 76.54 per share. | 05 May 2021 | 3,240 | 197,479 (0%) | 0% | 76.5 | 247,990 | Encompass Health Common Stock |
| April Kaye Bullock Anthony | CEO & President, Home Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.77 per share. | 05 May 2021 | 4,343 | 197,772 (0%) | 0% | 63.8 | 276,953 | Encompass Health Common Stock |
| April Kaye Bullock Anthony | CEO & President, Home Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.44 per share. | 03 May 2021 | 3,637 | 193,429 (0%) | 0% | 84.4 | 307,108 | Encompass Health Common Stock |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 247 | 80,009 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 11 | 3,108 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 84.27 per share. | 15 Apr 2021 | 167 | 120,521 (0%) | 0% | 84.3 | 14,073 | Encompass Health Common Stock |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 236 | 120,354 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 84.29 per share. | 15 Apr 2021 | 7 | 78,259 (0%) | 0% | 84.3 | 590 | Encompass Health Common Stock |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 247 | 78,252 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leo I. Higdon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 247 | 77,419 (0%) | 0% | 0 | Encompass Health Common Stock | |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 247 | 96,118 (0%) | 0% | 0 | Encompass Health Common Stock | |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 84.36 per share. | 15 Apr 2021 | 50 | 96,168 (0%) | 0% | 84.4 | 4,218 | Encompass Health Common Stock |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 247 | 74,249 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 97 | 29,392 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 97 | 29,392 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Yvonne M. Curl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 247 | 75,486 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 28 | 8,201 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 11 | 3,108 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 11 | 3,108 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Andrew Price | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 81.40 per share. | 08 Mar 2021 | 8,589 | 63,642 (0%) | 0% | 81.4 | 699,145 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 19,887 | 19,887 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 53,410 | 53,410 | - | - | Non-qualified Stock Option (Right to Buy) | |
| April Kaye Bullock Anthony | CEO & President, Home Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 9,375 | 9,375 | - | - | Non-qualified Stock Option (Right to Buy) | |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 9,375 | 9,375 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Barbara Jacobsmeyer | President, Inpatient Hospitals | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 16,620 | 16,620 | - | - | Non-qualified Stock Option (Right to Buy) | |
| April Kaye Bullock Anthony | CEO & President, Home Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 2,224 | 197,066 (0%) | 0% | 0 | Encompass Health Common Stock | |
| April Kaye Bullock Anthony | CEO & President, Home Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 3,449 | 194,842 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 1,699 | 89,947 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 2,088 | 88,248 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.23 per share. | 23 Feb 2021 | 312 | 86,160 (0%) | 0% | 80.2 | 25,032 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.23 per share. | 23 Feb 2021 | 790 | 64,257 (0%) | 0% | 80.2 | 63,382 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 9,275 | 73,532 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 4,717 | 78,249 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 12,669 | 397,551 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 30,468 | 384,882 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.23 per share. | 23 Feb 2021 | 1,975 | 354,414 (0%) | 0% | 80.2 | 158,454 | Encompass Health Common Stock |
| Andrew Price | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 1,806 | 72,231 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Andrew Price | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 2,088 | 70,425 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Andrew Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.23 per share. | 23 Feb 2021 | 314 | 68,337 (0%) | 0% | 80.2 | 25,192 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.23 per share. | 23 Feb 2021 | 356 | 16,846 (0%) | 0% | 80.2 | 28,562 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 2,485 | 19,331 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Elissa Joy Charbonneau | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 2,022 | 21,353 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.23 per share. | 23 Feb 2021 | 401 | 36,224 (0%) | 0% | 80.2 | 32,172 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 5,466 | 41,690 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 2,224 | 43,914 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Barbara Jacobsmeyer | President, Inpatient Hospitals | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.23 per share. | 23 Feb 2021 | 466 | 37,375 (0%) | 0% | 80.2 | 37,387 | Encompass Health Common Stock |
| Barbara Jacobsmeyer | President, Inpatient Hospitals | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 3,943 | 48,854 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Barbara Jacobsmeyer | President, Inpatient Hospitals | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 7,536 | 44,911 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 231 | 86,747 (0%) | 0% | 80.5 | 18,598 | Encompass Health Common Stock |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 275 | 86,472 (0%) | 0% | 80.5 | 22,140 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 621 | 65,047 (0%) | 0% | 80.5 | 49,997 | Encompass Health Common Stock |
| Douglas E. Coltharp | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 650 | 65,668 (0%) | 0% | 80.5 | 52,332 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 2,039 | 356,389 (0%) | 0% | 80.5 | 164,160 | Encompass Health Common Stock |
| Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 1,743 | 358,428 (0%) | 0% | 80.5 | 140,329 | Encompass Health Common Stock |
| Andrew Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 277 | 68,651 (0%) | 0% | 80.5 | 22,301 | Encompass Health Common Stock |
| Andrew Price | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 247 | 68,928 (0%) | 0% | 80.5 | 19,886 | Encompass Health Common Stock |
| April Kaye Bullock Anthony | CEO & President, Home Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 142 | 191,393 (0%) | 0% | 80.5 | 11,432 | Encompass Health Common Stock |
| April Kaye Bullock Anthony | CEO & President, Home Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 205 | 191,535 (0%) | 0% | 80.5 | 16,505 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 328 | 17,202 (0%) | 0% | 80.5 | 26,407 | Encompass Health Common Stock |
| Elissa Joy Charbonneau | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 275 | 17,530 (0%) | 0% | 80.5 | 22,140 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 366 | 36,625 (0%) | 0% | 80.5 | 29,467 | Encompass Health Common Stock |
| John Patrick Darby | EVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 305 | 36,991 (0%) | 0% | 80.5 | 24,556 | Encompass Health Common Stock |
| Barbara Jacobsmeyer | President, Inpatient Hospitals | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 505 | 37,841 (0%) | 0% | 80.5 | 40,658 | Encompass Health Common Stock |
| Barbara Jacobsmeyer | President, Inpatient Hospitals | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 543 | 38,346 (0%) | 0% | 80.5 | 43,717 | Encompass Health Common Stock |
| Charles M. Elson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 244 | 79,762 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Greg D. Carmichael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 11 | 3,097 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 233 | 119,946 (0%) | 0% | 0 | Encompass Health Common Stock | |
| John W. Chidsey | Director | Grant, award, or other acquisition of securities at price $ 83.26 per share. | 19 Jan 2021 | 172 | 120,118 (0%) | 0% | 83.3 | 14,321 | Encompass Health Common Stock |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 83.20 per share. | 19 Jan 2021 | 5 | 78,005 (0%) | 0% | 83.2 | 416 | Encompass Health Common Stock |
| John E. Maupin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 244 | 78,000 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leo I. Higdon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 244 | 77,172 (0%) | 0% | 0 | Encompass Health Common Stock | |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 83.22 per share. | 19 Jan 2021 | 49 | 95,871 (0%) | 0% | 83.2 | 4,078 | Encompass Health Common Stock |
| L. Edward Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 244 | 95,822 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Donald L. Correll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 244 | 74,002 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Leslye G. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 95 | 29,295 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Joan E. Herman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 95 | 29,295 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Yvonne M. Curl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 244 | 75,239 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Nancy M. Schlichting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 28 | 8,173 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Patricia Maryland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 11 | 3,097 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Terrance Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 11 | 3,097 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Edmund M. Fay | Sr. Vice Pres. and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.69 per share. | 04 Jan 2021 | 2,027 | 86,978 (0%) | 0% | 82.7 | 167,613 | Encompass Health Common Stock |